Abstract
In the old tradition of disease management, an abbreviated relation was consistently established between experimental and clinical observations compiled in a reductionist manner and the daily practice of diagnosis and therapy. By now, the gap between medical theory and therapeutic practice has been further operationalized by a formal-pragmatic communication theory that tends to only care for the transparency of basic concepts, i.e., the universality of scientific description and situative systems-immanent validity claims. Because of its ‘multilingualism’, a formal-pragmatic communication theory may uncover unexpected coherencies, for example, between experimentally and clinically detectable normative notions, i.e., normative tumor structures, action norms (rapid displacing growth, the ‘hallmarks’ of cancer, etc.), decision maxims (hubs), and their corresponding established rationalization processes that are concretely responsible for the fail-safe constitution (robustness) of tumor-associated normative notions. The first diagnostic step is to reconstruct the prerequisites for the situative identity and function of the systems objects (cells, pathways, etc.) in a tumor system. The results of these efforts—which constitute evolution-adjusted tumor pathophysiology—may advect in completely new therapeutic approaches. Such approaches may consist of biomodulatory multi-targeted therapies that are directed at hubs of tumor-associated rationalization processes constituting distinct normative notions. The communicative nature of configuring novel tumor pathophysiology may launch and shape discussion levels also from a clinical point of view. Clinically oriented tumor pathophysiology is pragmatically deployed by the inclusion of communication-derived benchmarks, i.e., modularity, subjectivity, intersubjectivity and normativity. Necessarily, the starting points for categorizing rationalization processes are pragmatically selected for their final presentation and therapeutic implementation. Intersystemic comparison of rationalization processes plays a crucial role. The pluralistic procedure indicates the pragmatic function of a communication theory for personalizing tumor therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reichle A, Hildebrandt GC (2009) Principles of modular tumor therapy. Cancer Microenviron 2(Suppl 1):227–237
Reichle A, Hildebrandt GC (2008) Systems biology: a therapeutic target for tumor therapy. Cancer Microenviron 1(1):159–170
Reichle A, Hildebrandt GC (2010) To be an object in a biological system: the necessity of a formal-pragmatic communication theory. In: From molecular to modular tumor therapy: the tumor microenvironment, vol 3, part 9. Springer, pp 537–544. doi:10.1007/978–90-481–9531-2_26
Reichle A, Hildebrandt GC (2010) The comparative uncovering of tumor systems biology by modularly targeting tumor-associated inflammation. In: From molecular to modular tumor therapy: the tumor microenvironment, vol 3, part 4. Springer, pp 287–303. doi:10.1007/978–90-481-9531-2_13
Reichle A (2010) Bridging theory and therapeutic practice: from generalized disease models to particular patients In: From molecular to modular tumor therapy. The tumor microenvironment, vol 3, Springer, doi:10.1007/978–90-481-9531-2_1
Reichle A, Hildebrandt GC (2010) From molecular to modular from theme-dependent to evolution-adjusted tumor therapy. In: From molecular to modular tumor therapy The tumor microenvironment, vol 3, part 7. Springer, pp 467–489. doi:10.1007/978–90-481-9531-2_27
Turner NC, Reis-Filho JS (2012) Genetic heterogeneity and cancer drug resistance. Lancet Oncol 13(4):e178–185
Reichle A, Hildebrandt GC (2010) Searching for the ‘Metabolism’ of Evolution. From molecular to modular tumor therapy: the tumor microenvironment, vol 3, part 4. Springer, pp 305–309. doi: 10.1007/978-90-481-9531-2_14
Habermas J (1992) Between facts and norms: contributions to a discourse theory of law and democracy ISBN 3–518-28961
Reichle A, Hildebrandt GC (2010) Uncovering tumor systems biology by biomodulatory therapy strategies. From molecular to modular tumor therapy: the tumor microenvironment, vol 3, part 4. Springer, pp 287–303. doi:10.1007/978–90-481–9531-2_13
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Reichle, A. (2013). Modularity, Subjectivity, Intersubjectivity and Normativity: Clinically Applicable Operative Benchmarks. In: Reichle, A. (eds) Evolution-adjusted Tumor Pathophysiology:. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6866-6_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-6866-6_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6865-9
Online ISBN: 978-94-007-6866-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)